Attached files
file | filename |
---|---|
10-K - FORM 10-K - Protalix BioTherapeutics, Inc. | y03091e10vk.htm |
EX-31.2 - EX-31.2 - Protalix BioTherapeutics, Inc. | y03091exv31w2.htm |
EX-21.1 - EX-21.1 - Protalix BioTherapeutics, Inc. | y03091exv21w1.htm |
EX-31.1 - EX-31.1 - Protalix BioTherapeutics, Inc. | y03091exv31w1.htm |
EX-23.1 - EX-23.1 - Protalix BioTherapeutics, Inc. | y03091exv23w1.htm |
EX-10.16 - EX-10.16 - Protalix BioTherapeutics, Inc. | y03091exv10w16.htm |
EX-32.2 - EX-32.2 - Protalix BioTherapeutics, Inc. | y03091exv32w2.htm |
EXHIBIT 32.1
PROTALIX BIOTHERAPEUTICS, INC.
CERTIFICATION
In connection with the Annual Report of Protalix BioTherapeutics, Inc. (the Company) on Form 10-K
for the period ended December 31, 2009 as filed with the Securities and Exchange Commission (the
Report), I, David Aviezer, President and Chief Executive Officer of the Company, hereby certify
as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United
States Code, that to the best of my knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and |
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. |
This Certification has not been, and shall not be deemed, filed with the Securities and Exchange
Commission.
Date: February 25, 2010
/s/ David Aviezer
|
||
President and Chief Executive Officer |